Notify me when SymBiosis Capital Partners, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. | Class A Common Stock | 6.5% | 6,300,000 | SymBiosis Capital Partners, LLC | 13 Nov 2025 | ||||
| GBIO | Generation Bio Co. | Common Stock | 6.3% | $2,582,018 | 421,926 | SymBiosis Capital Partners, LLC | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|